Rare Diseases: A Diagnostic Odyssey

Unravelling the Complexities of Rare Diseases: A Market Research Perspective

The diagnostic journey for individuals with rare diseases is often a complex and prolonged process, filled with uncertainty. Unlike readily identifiable conditions, rare diseases lack clear diagnostic pathways, leaving patients and physicians navigating a complex web of potential diagnoses and specialist referrals. This prolonged diagnostic odyssey can significantly delay treatment, impacting patient outcomes and quality of life. 

This article provides valuable insights for market researchers seeking to understand the unique challenges and opportunities within the rare disease landscape. It explores how leveraging innovative market research is pivotal in addressing these challenges. By enhancing understanding of rare diseases and informing treatment strategies, pharmaceutical companies can improve diagnostic experiences and enhance treatment outcomes.

Download ‘Rare Diseases: A Diagnostic Odyssey’

Download

The author(s)

Related news

  • The Human Advantage Conference 2026: Highlights
    Artificial Intelligence (AI) Events replay

    The Human Advantage Conference 2026: Highlights

    Ipsos is proud to support The Human Advantage 2026, a flagship event bringing together some of the world's leading experts and key industry figures to explore how behavioural science, AI, and human intelligence can address the critical challenges facing businesses and society. Here's a look back at two days of live coverage.
  • [WEBINAR] KEYS: Dialling Up the S In Sustainability
    KEYS Events replay

    [REPLAY] KEYS: Dialling Up the S In Sustainability

    In the next episode of our KEYS webinar, we’ll be asking whether now is the time when organisations should be ‘dialling up the S’ in their sustainability initiatives.
  • [Webinar] Real-World Evidence: Empowering the Patient
    Healthcare Webinar

    [Replay] Real-World Evidence: Empowering the Patient

    Patient voices are now central to regulatory, HTA and commercial decisions. But how do we move beyond tick-box engagement to evidence that truly reflects lived experience? Join our expert panel for a 360° perspective on making patient-centricity work in practice.